首页> 外国专利> OXIDIZED MANNAN-T/TN CONJUGATE AND CANCER VACCINE COMPOSITION COMPRISING THE SAME TO PREVENT INITIAL CANCER PRODUCTION AS WELL AS CANCER RECURRENCE

OXIDIZED MANNAN-T/TN CONJUGATE AND CANCER VACCINE COMPOSITION COMPRISING THE SAME TO PREVENT INITIAL CANCER PRODUCTION AS WELL AS CANCER RECURRENCE

机译:氧化的MANNAN-T / TN共轭物和癌疫苗组合物,其组成相同,可防止初始癌症的产生以及癌症的复发

摘要

PURPOSE: An oxidized mannan-T/Tn conjugate and a cancer vaccine composition comprising the same conjugate are provided. The cancer vaccine composition induces humoral immunity and cell-mediated immunity, so that initial cancer production as well as cancer recurrence can be prevented, and autoimmunity problem can be resolved. CONSTITUTION: The oxidized mannan-T/Tn conjugate is prepared by connecting oxidized mannan with a T/Tn glycoprotein antigen. The cancer vaccine composition comprises the oxidized mannan-T/Tn conjugate and pharmaceutically acceptable carriers, wherein the cancer vaccine composition induces cell-mediated immunity; the cancer vaccine composition further comprises immunity adjuvant such as Freund's adjuvant; and the weight ratio of the oxidized mannan-T/Tn conjugate to immunity adjuvant is 2:3 to 3:2.
机译:目的:提供氧化的甘露聚糖-T / Tn缀合物和包含相同缀合物的癌症疫苗组合物。该癌症疫苗组合物诱导体液免疫和细胞介导的免疫,从而可以防止最初的癌症产生以及癌症复发,并且可以解决自身免疫问题。组成:氧化甘露聚糖-T / Tn偶联物是通过将氧化甘露聚糖与T / Tn糖蛋白抗原连接而制备的。所述癌症疫苗组合物包含氧化的甘露聚糖-T / Tn缀合物和药学上可接受的载体,其中所述癌症疫苗组合物诱导细胞介导的免疫。所述癌症疫苗组合物还包含免疫佐剂,例如弗氏佐剂。氧化的甘露聚糖-T / Tn缀合物与免疫佐剂的重量比为2:3至3:2。

著录项

  • 公开/公告号KR20040088864A

    专利类型

  • 公开/公告日2004-10-20

    原文格式PDF

  • 申请/专利权人 KIM CHUL WOO;NOUVAX CO. LTD.;

    申请/专利号KR20030023276

  • 发明设计人 KIM CHUL WOO;SON HYE YEON;

    申请日2003-04-14

  • 分类号C07K14/47;

  • 国家 KR

  • 入库时间 2022-08-21 22:47:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号